Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05546437 · ClinicalTrials.gov registry record
A Multicenter Retrospective Review to Evaluate the Feasibility of Dye Marking Using the Ion Endoluminal System
A clinical trial, sponsored by Intuitive Surgical.
- Completed
- Registry status
- 288
- Enrollment target
NCT05546437: Completed study, sponsored by Intuitive Surgical.
NCT05546437 is a clinical trial that has completed, run by Intuitive Surgical. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05546437 has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- 288 participants
- Enrollment target
Study Summary
The overall objective of this study is to assess the ability of the Ion Endoluminal System to perform pleural based tissue dye marking in anticipation of a lung resection.
Primary Outcome
The ability of the investigator to localize the marked lesion during resection, assessed by successful injection of dye, localization of due within the targeted area, and the ability to visualize the dye marking intra-operatively or on resected sample
Interventions
- DEVICE Ion Endoluminal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2023-12-31 |
What the finished NCT05546437 record still lists
NCT05546437 is an observational study that tracks outcomes without assigning an intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Ion Endoluminal System is the first listed.
NCT05546437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05546437 about?
NCT05546437 is a clinical study titled "A Multicenter Retrospective Review to Evaluate the Feasibility of Dye Marking Using the Ion Endoluminal System". The overall objective of this study is to assess the ability of the Ion Endoluminal System to perform pleural based tissue dye marking in anticipation of a lung resection.
What is the current status of trial NCT05546437?
This trial is currently completed. The enrollment target is 288 participants. The study started on 2022-07-22. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05546437?
The interventions under investigation include: Ion Endoluminal System (DEVICE).
Who is sponsoring clinical trial NCT05546437?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI